SCA practice case · Video consultation

“My routine blood test showed raised lymphocytes and the word ‘leukaemia’ — I’m terrified, but I feel completely well”

Video consultation Older adult patient Typical Long-term conditions & cancerInvestigations & resultsOlder adults

The candidate brief

This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.

Patient
Edward Ross · 69 years · male
Setting
Video consultation — discussing a routine blood test result
Past history
  • None recorded
Medication
  • None recorded
Allergies
None recorded
Recent notes
Pre-op FBC: isolated lymphocytosis; film and flow suggest CLL. Well. Pre-operative assessment clinic letter, 2 weeks ago (planned inguinal hernia repair): well; no palpable lymph nodes, liver or spleen; observations normal. FBC: lymphocytes 11.2 × 10⁹/L, Hb 141 g/L, platelets 210 × 10⁹/L, neutrophils normal; film and flow cytometry suggest CLL.
Reason for contact
“Does this mean I’m dying?”

Practise this case

The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.

What this case tests

Show the learning points (spoiler: read after you have practised)
A persistent, isolated mature LYMPHOCYTOSIS in an older adult is commonly CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL), confirmed by blood film and FLOW CYTOMETRY/immunophenotyping (iwCLL 2018, international: at least 5 × 10⁹/L clonal B lymphocytes; lower counts without node or organ involvement are monoclonal B-cell lymphocytosis), and is often INDOLENT and frequently diagnosed INCIDENTALLY in well, asymptomatic patients. Assess for clinical features and staging pointers — lymphadenopathy, hepatosplenomegaly, B symptoms (unexplained weight loss, drenching night sweats, fevers), anaemia/thrombocytopenia, and recurrent infections — and refer to HAEMATOLOGY for confirmation, staging (Binet/Rai) and a management plan. The reassuring reality to explain is "WATCH AND WAIT": many early-stage CLL patients need no treatment for years (sometimes never), are monitored with periodic bloods/review, and can have a near-normal life expectancy, with treatment reserved for progressive/symptomatic disease (rising counts/organomegaly, cytopenias, B symptoms). Counsel infection risk — CLL impairs immunity, so vaccinations (influenza, pneumococcal, COVID-19; check Shingrix eligibility; avoid live vaccines — Green Book), sun protection because skin cancers are more common, prompt treatment of infections, and reporting fevers/recurrent infections matter — and advise what to monitor/report (B symptoms, new lumps, infections, bleeding/bruising, fatigue). The communication core is the word "leukaemia": be honest that it is a cancer but provide calibrated reassurance (often very indolent, many never need treatment, near-normal life expectancy in many) without false promises or minimising, supporting both patient and family. Referral for a well patient with isolated lymphocytosis and normal haemoglobin and platelets is usually through the local haematology pathway, with faster review for cytopenias, bulky nodes, B symptoms or a rapid rise (BSH 2022); NICE NG12 very urgent FBC applies to adults with features of leukaemia, and a suspected cancer pathway referral is not the route once flow cytometry suggests CLL in a well patient. Inform the pre-operative team.

The guidance behind it

Similar SCA cases

Browse all 359 cases by experience group →

gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.